Crystal structure of I-Ak in complex with a dominant epitope of lysozyme

被引:223
作者
Fremont, DH [1 ]
Monnaie, D
Nelson, CA
Hendrickson, WA
Unanue, ER
机构
[1] Washington Univ, Sch Med, Ctr Immunol, Dept Pathol, St Louis, MO 63110 USA
[2] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA
关键词
D O I
10.1016/S1074-7613(00)80536-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have determined the structure of murine MHC class II I-A(k) in complex with a naturally processed peptide from hen egg lysozyme (HEL residues 50-62) at 1.9 Angstrom resolution. These results provide a structural basis for the I-A(k) peptide-binding motif. Binding is established by the deep burial of five anchor side chains into specific pockets of the I-A(k) binding groove, with a ten-like fit of an aspartic acid in the P1 pocket. We also show that in the I-A(k) alpha chain, a bulge occurs in the first strand of the peptide-binding platform, an insertion probably common to all I-A and HLA-DQ alleles. The I-A(k) beta chain has a deletion in the helical region adjacent to the P7 pocket and an insertion in the helical region neighboring the P1 pocket. As a result of these structural features, the extended HEL peptide dips low into the center of the I-A(k) groove and reaches toward solvent at its C-terminal end.
引用
收藏
页码:305 / 317
页数:13
相关论文
共 50 条
[1]   THE 1ST EXTERNAL DOMAIN OF THE NONOBESE DIABETIC MOUSE CLASS-II I-A BETA-CHAIN IS UNIQUE [J].
ACHAORBEA, H ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) :2435-2439
[2]   MECHANISMS INFLUENCING THE IMMUNODOMINANCE OF T-CELL DETERMINANTS [J].
ADORINI, L ;
APPELLA, E ;
DORIA, G ;
NAGY, ZA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (06) :2091-2104
[3]  
ALLEN PM, 1984, J IMMUNOL, V132, P1077
[4]   IDENTIFICATION OF THE T-CELL AND IA CONTACT RESIDUES OF A T-CELL ANTIGENIC EPITOPE [J].
ALLEN, PM ;
MATSUEDA, GR ;
EVANS, RJ ;
DUNBAR, JB ;
MARSHALL, GR ;
UNANUE, ER .
NATURE, 1987, 327 (6124) :713-715
[5]   BINDING OF IMMUNOGENIC PEPTIDES TO IA HISTOCOMPATIBILITY MOLECULES [J].
BABBITT, BP ;
ALLEN, PM ;
MATSUEDA, G ;
HABER, E ;
UNANUE, ER .
NATURE, 1985, 317 (6035) :359-361
[6]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[7]   CRYSTALLOGRAPHIC R-FACTOR REFINEMENT BY MOLECULAR-DYNAMICS [J].
BRUNGER, AT ;
KURIYAN, J ;
KARPLUS, M .
SCIENCE, 1987, 235 (4787) :458-460
[8]   THE RELATION BETWEEN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) RESTRICTION AND THE CAPACITY OF IA TO BIND IMMUNOGENIC PEPTIDES [J].
BUUS, S ;
SETTE, A ;
COLON, SM ;
MILES, C ;
GREY, HM .
SCIENCE, 1987, 235 (4794) :1353-1358
[9]   RIBBON MODELS OF MACROMOLECULES [J].
CARSON, M .
JOURNAL OF MOLECULAR GRAPHICS, 1987, 5 (02) :103-&
[10]   T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage [J].
Carson, RT ;
Vignali, KM ;
Woodland, DL ;
Vignali, DAA .
IMMUNITY, 1997, 7 (03) :387-399